These clinical entities share pathological and immune features with idiopathic pulmonary fibrosis (IPF), a paradigmatic chronic progressive fibrosing disease whose chemokine biomarkers include CCL18 and CXCL13 (80–84). The gene discussed is CCL18; the disease is idiopathic pulmonary fibrosis.